These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 7537194

  • 1. Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia.
    Fulton B, Wagstaff AJ, Sorkin EM.
    Drugs; 1995 Feb; 49(2):295-320. PubMed ID: 7537194
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A multicenter, community-based study of doxazosin in the treatment of concomitant hypertension and symptomatic benign prostatic hyperplasia: the Hypertension and BPH Intervention Trial (HABIT).
    Guthrie RM, Siegel RL.
    Clin Ther; 1999 Oct; 21(10):1732-48. PubMed ID: 10566569
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Patients with uncontrolled hypertension or concomitant hypertension and benign prostatic hyperplasia.
    Zusman R.
    Clin Cardiol; 2004 Feb; 27(2):63-9. PubMed ID: 14979621
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Doxazosin: a new alpha 1-adrenergic antagonist.
    Babamoto KS, Hirokawa WT.
    Clin Pharm; 1992 May; 11(5):415-27. PubMed ID: 1349855
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Profile of doxazosin in the hypertensive man with benign prostatic hyperplasia.
    Kirby RS.
    Br J Clin Pract Suppl; 1994 May; 74():23-8. PubMed ID: 7519438
    [Abstract] [Full Text] [Related]

  • 13. Doxazosin in the current treatment of hypertension.
    Wykretowicz A, Guzik P, Wysocki H.
    Expert Opin Pharmacother; 2008 Mar; 9(4):625-33. PubMed ID: 18312163
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.
    Kyprianou N.
    J Urol; 2003 Apr; 169(4):1520-5. PubMed ID: 12629407
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. After ALLHAT: doxazosin for the treatment of benign prostatic hyperplasia.
    Doggrell SA.
    Expert Opin Pharmacother; 2004 Sep; 5(9):1957-64. PubMed ID: 15330733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.